Current role
Shell Companies · Financial Services
CEO
2026-02-28–present
Roger Bendelac
Equibles does not estimate personal net worth.
Get an email with a short summary when Drugs Made In America Acquisition II Corp. publishes a filing, an earnings call transcript or a press release.
Get DMII alertsAbout Roger Bendelac
Roger Bendelac is recorded as CEO at Drugs Made In America Acquisition II Corp. (DMII) since February 28, 2026. Drugs Made In America Acquisition II Corp. reported in an 8-K filed March 6, 2026 that Roger Bendelac was appointed Chief Executive Officer, effective February 28, 2026. Drugs Made In America Acquisition II Corp. is classified in the Shell Companies industry within the Financial Services sector. Other leadership on record at Drugs Made In America Acquisition II Corp. includes Saleem Elmasri (CFO and Chief Accounting Officer), Catherine Do (Board Member), G. Sridhar Prasad (Board Member) and 1 other.
“On February 28, 2026, Roger Bendelac was appointed to the position of Chief Executive Officer of the Company to be effective as of the date of Ms. Stockwell's resignation as the Company's Chief Executive Officer.”
Affiliation history
-
Current
2026-02-28–present
Company network
Leadership on record at Drugs Made In America Acquisition II Corp.
- Saleem Elmasri CFO, Chief Accounting Officer
- Catherine Do Board Member
- G. Sridhar Prasad Board Member
- Myron W. Shulgan Board Member